{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:20:37Z","timestamp":1768800037712,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10072-019-04216-4","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:05:58Z","timestamp":1577991958000},"page":"1125-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum adiponectin levels between patients with Parkinson\u2019s disease and those with PSP"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-5447","authenticated-orcid":false,"given":"Hiroshi","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"4216_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MOL.0b013e32814a645f","volume":"18","author":"C Lara-Castro","year":"2007","unstructured":"Lara-Castro C, Fu Y, Chung BH, Garvey WT (2007) Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18:263\u2013270","journal-title":"Curr Opin Lipidol"},{"key":"4216_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","volume":"13","author":"A Parimisetty","year":"2016","unstructured":"Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d'Hellencourt C (2016) Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation 13:67","journal-title":"J Neuroinflammation"},{"key":"4216_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.107.725044","volume":"117","author":"M Nishimura","year":"2008","unstructured":"Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, Shin HK, Moskowitz MA, Ouchi N (2008) Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117:216\u2013223","journal-title":"Circulation"},{"key":"4216_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.bbadis.2015.06.019","volume":"1852","author":"Y Yang","year":"2015","unstructured":"Yang Y, Hu W, Jiang S, Wang B, Li Y, Fan C, Di S, Ma Z, Lau WB, Qu Y (2015) The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases. Biochim Biophys Acta 1852:1887\u20131894","journal-title":"Biochim Biophys Acta"},{"key":"4216_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02251202","volume":"5","author":"HS Markus","year":"1993","unstructured":"Markus HS, Tomkins AM, Stern GM (1993) Increased prevalence of undernutrition in Parkinson\u2019s disease and its relationship to clinical disease parameters. J Neural Transm Park Dis Dement Sect 5:117\u2013125","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"4216_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/cs0830199","volume":"83","author":"HS Markus","year":"1992","unstructured":"Markus HS, Cox M, Tomkins AM (1992) Raised resting energy expenditure in Parkinson\u2019s disease and its relationship to muscle rigidity. Clin Sci (Lond) 83:199\u2013204","journal-title":"Clin Sci (Lond)"},{"key":"4216_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.metabol.2012.06.001","volume":"61","author":"LY Quan Li","year":"2012","unstructured":"Quan Li LY, Sun L, Yan J, Yan X, Fang L, Li M, Fan Z (2012) Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism 61:1803\u20131808","journal-title":"Metabolism"},{"key":"4216_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","volume":"37","author":"G Scigliano","year":"2006","unstructured":"Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F (2006) Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37:1184\u20131188","journal-title":"Stroke"},{"key":"4216_CR9","first-page":"624764","volume":"2011","author":"E Cassani","year":"2011","unstructured":"Cassani E, Cancello R, Cavanna F, Maestrini S, Di Blasio AM, Liuzzi A, Pezzoli G, Barichella M (2011) Serum adiponectin levels in advanced-stage Parkinson\u2019s disease patients. Parkinsons Dis 2011:624764","journal-title":"Parkinsons Dis"},{"key":"4216_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1476-5381.2011.01560.x","volume":"165","author":"J Thundyil","year":"2012","unstructured":"Thundyil J, Pavlovski D, Sobey CG, Arumugam TV (2012) Adiponectin receptor signalling in the brain. Br J Pharmacol 165:313\u2013327","journal-title":"Br J Pharmacol"},{"key":"4216_CR11","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1002\/cne.23389","volume":"521","author":"E Matsunaga","year":"2013","unstructured":"Matsunaga E, Nambu S, Oka M, Iriki A (2013) Differential cadherin expression in the developing postnatal telencephalon of a New World monkey. J Comp Neurol 521:4027\u20134060","journal-title":"J Comp Neurol"},{"key":"4216_CR12","doi-asserted-by":"publisher","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE (2000) Alpha-synuclein membrane interactions and lipid specificity. J Biol Chem 275:34328\u201334334","journal-title":"J Biol Chem"},{"key":"4216_CR13","doi-asserted-by":"publisher","first-page":"17625","DOI":"10.1038\/srep17625","volume":"5","author":"K Araki","year":"2015","unstructured":"Araki K, Yagi N, Ikemoto Y, Yagi H, Choong CJ, Hayakawa H, Beck G, Sumi H, Fujimura H, Moriwaki T, Nagai Y, Goto Y, Mochizuki H (2015) Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson\u2019s disease patients. Sci Rep 5:17625","journal-title":"Sci Rep"},{"key":"4216_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/acn3.77","volume":"1","author":"K Sekiyama","year":"2014","unstructured":"Sekiyama K, Waragai M, Akatsu H, Sugama S, Takenouchi T, Takamatsu Y, Fujita M, Sekigawa A, Rockenstein E, Inoue S, La Spada AR, Masliah E, Hashimoto M (2014) Disease-modifying effect of adiponectin in model of \u03b1-synucleinopathies. Ann Clin Transl Neurol 1:479\u2013489","journal-title":"Ann Clin Transl Neurol"},{"key":"4216_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/00207454.2013.846340","volume":"124","author":"X Li","year":"2014","unstructured":"Li X, Geng J, Liu J (2014) Adiponectin offers protection against L166P mutant DJ-1-induced neuronal cytotoxicity mediated by APPL1-dependent AMPK activation. Int J Neurosci 124:350\u2013361","journal-title":"Int J Neurosci"},{"key":"4216_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4216_CR17","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mds.23192","volume":"25","author":"M K\u00f6llensperger","year":"2010","unstructured":"K\u00f6llensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK, EMSA-SG (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25:2604\u20132612","journal-title":"Mov Disord"},{"key":"4216_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, D\u00fcrr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"4216_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSP Study Group (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"4216_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnins.2018.00128","volume":"12","author":"R Marin","year":"2018","unstructured":"Marin R, Diaz M (2018) Estrogen interactions with lipid rafts related to neuroprotection impact of brain ageing and menopause. Front Neurosci 12:128","journal-title":"Front Neurosci"},{"issue":"9\u201310","key":"4216_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo N, Mart\u00edn V, Santpere G, Mar\u00edn R, Torrent L, Ferrer I, D\u00edaz M (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol Med 17(9\u201310):1107\u20131118","journal-title":"Mol Med"},{"key":"4216_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","volume":"64","author":"E Dalf\u00f3","year":"2005","unstructured":"Dalf\u00f3 E, Portero-Ot\u00edn M, Ayala V, Mart\u00ednez A, Pamplona R, Ferrer I (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:816\u2013830","journal-title":"J Neuropathol Exp Neurol"},{"key":"4216_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2016.08.027","volume":"49","author":"R Marin","year":"2017","unstructured":"Marin R, Fabelo N, Mart\u00edn V, Garcia-Esparcia P, Ferrer I, Quinto-Alemany D, D\u00edaz M (2017) Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer\u2019s and Parkinson\u2019s diseases. Neurobiol Aging 49:52\u201359","journal-title":"Neurobiol Aging"},{"key":"4216_CR24","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","volume":"291","author":"F Samuel","year":"2016","unstructured":"Samuel F, Flavin WP, Iqbal S, Pacelli C, Sri Renganathan SD, Trudeau LE, Campbell EM, Fraser PE, Tandon A (2016) Effects of serine 129 phosphorylation on \u03b1-synuclein aggregation, membrane association, and internalization. J Biol Chem 291:4374\u20134385","journal-title":"J Biol Chem"},{"issue":"1","key":"4216_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2014.02.077","volume":"446","author":"Z Wan","year":"2014","unstructured":"Wan Z, Mah D, Simtchouk S, Klegeris A, Little JP (2014) Globular adiponectin induces a pro-inflammatory response in human astrocytic cells. Biochem Biophys Res Commun 446(1):37\u201342","journal-title":"Biochem Biophys Res Commun"},{"key":"4216_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diabetes.55.01.06.db05-1077","volume":"55","author":"J Spranger","year":"2006","unstructured":"Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tsch\u00f6p M, Banks WA (2006) Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55:141\u2013147","journal-title":"Diabetes"},{"key":"4216_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cyto.2019.03.009","volume":"119","author":"TA Diniz","year":"2019","unstructured":"Diniz TA, Aquino J\u00fanior JCJ, Mosele FC, Cabral-Santos C, Lima Junior EA, Teixeira AAS, Lira FS, Rosa Neto JC (2019) Exercise-induced AMPK activation and IL-6 muscle production are disturbed in adiponectin knockout mice. Cytokine 119:71\u201380","journal-title":"Cytokine"},{"key":"4216_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85\u201397","journal-title":"Nat Rev Immunol"},{"key":"4216_CR29","doi-asserted-by":"publisher","first-page":"e47387","DOI":"10.1371\/journal.pone.0047387","volume":"7","author":"D Lindqvist","year":"2012","unstructured":"Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O (2012) Non-motor symptoms in patients with Parkinson\u2019s disease - correlations with inflammatory cytokines in serum. PLoS One 7:e47387","journal-title":"PLoS One"},{"key":"4216_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","volume":"468","author":"P Scalzo","year":"2010","unstructured":"Scalzo P, K\u00fcmmer A, Cardoso F, Teixeira AL (2010) Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance. Neurosci Lett 468:56\u201358","journal-title":"Neurosci Lett"},{"key":"4216_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73:1316\u20131324","journal-title":"JAMA Neurol"},{"key":"4216_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00221-017-4978-4","volume":"235","author":"G N\u00fcbling","year":"2017","unstructured":"N\u00fcbling G, Schuberth M, Feldmer K, Giese A, Holdt LM, Teupser D, Lorenzl S (2017) Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy. Exp Brain Res 235:2407\u20132412","journal-title":"Exp Brain Res"},{"issue":"1\u20132","key":"4216_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2014.01.021","volume":"339","author":"NP Rocha","year":"2014","unstructured":"Rocha NP, Scalzo PL, Barbosa IG, de Sousa MS, Morato IB, Vieira EL, Christo PP, Reis HJ, Teixeira AL (2014) Circulating levels of adipokines in Parkinson\u2019s disease. J Neurol Sci 339(1\u20132):64\u201368","journal-title":"J Neurol Sci"},{"issue":"7","key":"4216_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5551\/jat.7039","volume":"18","author":"Y Arai","year":"2011","unstructured":"Arai Y, Takayama M, Abe Y, Hirose N (2011) Adipokines and aging. J Atheroscler Thromb 18(7):545\u2013550","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"4216_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46(4):459\u2013469","journal-title":"Diabetologia"},{"key":"4216_CR36","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1210\/jc.2005-2714","volume":"91","author":"N Bansal","year":"2006","unstructured":"Bansal N, Charlton-Menys V, Pemberton P, McElduff P, Oldroyd J, Vyas A, Koudsi A, Clayton PE, Cruickshank JK, Durrington PN (2006) Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicity. J Clin Endocrinol Metab 91:2244\u20132249","journal-title":"J Clin Endocrinol Metab"},{"key":"4216_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.111.025445","volume":"124","author":"S Chung","year":"2011","unstructured":"Chung S, Sawyer JK, Gebre AK, Maeda N, Parks JS (2011) Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo. Circulation 124:1663\u20131672","journal-title":"Circulation"},{"key":"4216_CR38","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.109.897330","volume":"121","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, McGillicuddy FC, Hinkle CC, O'Neill S, Glick JM, Rothblat GH, Reilly MP (2010) Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 121:1347\u20131355","journal-title":"Circulation"},{"key":"4216_CR39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","volume":"289","author":"K Esposito","year":"2003","unstructured":"Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. J Am Med Assoc 289:1799\u20131804","journal-title":"J Am Med Assoc"},{"key":"4216_CR40","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1210\/jc.2003-031777","volume":"89","author":"R Baratta","year":"2004","unstructured":"Baratta R, Amato S, Degano C, Farina MG, Patan\u00e8 G, Vigneri R, Frittitta L (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665\u20132671","journal-title":"J Clin Endocrinol Metab"},{"key":"4216_CR41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.10577","volume":"53","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson\u2019s disease. Ann Neurol 53:676\u2013679","journal-title":"Ann Neurol"},{"key":"4216_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s13760-017-0798-3","volume":"117","author":"HR Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez HR, Escamilla-Oca\u00f1as CE, Camara-Lemarroy CR, Gonz\u00e1lez-Garza MT, Tenorio-Pedraza JM, Hern\u00e1ndez-Torre M (2017) CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis. Acta Neurol Belg 117:879\u2013883","journal-title":"Acta Neurol Belg"},{"key":"4216_CR43","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","volume":"51","author":"H Nishizawa","year":"2002","unstructured":"Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734\u20132741","journal-title":"Diabetes"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04216-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T16:01:13Z","timestamp":1722268873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04216-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04216-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"24 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the medical ethics committee of Nara Medical University. No investigations or interventions were performed outside of routine clinical care for these patients. As this is case series, without experimental intervention into routine care, the authors confirm that [the approval of an institutional review board]\/[patient consent] was not required for this work and no formal research ethics approval was required. Written, fully informed consent was received from the routine clinical care for these patients. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}